Lnc2Cancer

Experimentally Supported Human LncRNA and Cancer Associations Database

LncRNA centric

Cancer centric

Advanced search

Drug resistant

Circulating

Prognosis

Detail


   LncRNA Name BALR-6
   Synonyms NA
   Region NA    Sequence
   Ensembl NA
   RefSeq NA
   Circulating
   Drug-resisitant
   Prognostic
   MiRNA
   Variant
   TF
   Methylation
   Cancer Name B-lymphoblastic leukemia
   ICD-0-3  M9811/3
   Methods qPCR, RNAi, Northern blot etc.
   Sample cell lines (MV, Reh, 697, Nalm-6, 70Z/3, HEK 293)
   Expression Pattern up-regulated
   Function Description

Overexpression of BALR-6 in murine bone marrow transplantation experiments caused a significant increase in early hematopoietic progenitor populations, suggesting that its dysregulation may cause developmental changes. Notably, the knockdown of BALR-6 resulted in global dysregulation of gene expression. The gene set was enriched for leukemia-associated genes, as well as for the transcriptome regulated by Specificity Protein 1 (SP1). We confirmed changes in the expression of SP1, as well as its known interactor and downstream target CREB1. Luciferase reporter assays demonstrated an enhancement of SP1-mediated transcription in the presence of BALR-6. These data provide a putative mechanism for regulation by BALR-6 in B-ALL

   Pubmed ID 26694754
   Year 2015
   Title BALR-6 regulates cell growth and cell survival in B-lymphoblastic leukemia
   External Links
   Links for  BALR-6 GenBank       HGNC       lncrnadb       Noncode
   Links for  B-lymphoblastic leukemia Omim       Cosmic

CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.